Sfoglia per Autore
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
2023-01-01 Scheiner, B.; Roessler, D.; Phen, S.; Lim, M.; Pomej, K.; Pressiani, T.; Cammarota, A.; Frundt, T. W.; von Felden, J.; Schulze, K.; Himmelsbach, V.; Finkelmeier, F.; Deibel, A.; Siebenhuner, A. R.; Shmanko, K.; Radu, P.; Schwacha-Eipper, B.; Ebert, M. P.; Teufel, A.; Djanani, A.; Hucke, F.; Balcar, L.; Philipp, A. B.; Hsiehchen, D.; Venerito, M.; Sinner, F.; Trauner, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Pinato, D. J.; Peck-Radosavljevic, M.; Dufour, J. -F.; Weinmann, A.; Kremer, A. E.; Singal, A. G.; De Toni, E. N.; Rimassa, L.; Pinter, M.
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
2023-01-01 Vithayathil, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Zanuso, V.; Pressiani, T.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.; Sharma, R.
Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials
2023-01-01 Fulgenzi, C. A. M.; Scheiner, B.; Korolewicz, J.; Stikas, C. -V.; Gennari, A.; Vincenzi, B.; Openshaw, M. R.; Silletta, M.; Pinter, M.; Cortellini, A.; Scotti, L.; D'Alessio, A.; Pinato, D. J.
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
2023-01-01 Tagliamento, Marco; Gennari, Alessandra; Lambertini, Matteo; Salazar, Ramon; Harbeck, Nadia; Del Mastro, Lucia; Aguilar-Company, Juan; Bower, Mark; Sharkey, Rachel; Dalla Pria, Alessia; Plaja, Andrea; Jackson, Amanda; Handford, Jasmine; Sita-Lumsden, Ailsa; Martinez-Vila, Clara; Matas, Marta; Miguel Rodriguez, Ana; Vincenzi, Bruno; Tonini, Giuseppe; Bertuzzi, Alexia; Brunet, Joan; Pedrazzoli, Paolo; D'Avanzo, Francesca; Biello, Federica; Sinclair, Alasdair; Lee, Alvin J X; Rossi, Sabrina; Rizzo, Gianpiero; Mirallas, Oriol; Pimentel, Isabel; Iglesias, Maria; Sanchez de Torre, Ana; Guida, Annalisa; Berardi, Rossana; Zambelli, Alberto; Tondini, Carlo; Filetti, Marco; Mazzoni, Francesca; Mukherjee, Uma; Diamantis, Nikolaos; Parisi, Alessandro; Aujayeb, Avinash; Prat, Aleix; Libertini, Michela; Grisanti, Salvatore; Rossi, Maura; Zoratto, Federica; Generali, Daniele; Saura, Cristina; Lyman, Gary H; Kuderer, Nicole M; Pinato, David J; Cortellini, Alessio
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC
2023-01-01 Chen, M.; Lu, H.; Copley, S. J.; Han, Y.; Logan, A.; Viola, P.; Cortellini, A.; Pinato, D. J.; Power, D.; Aboagye, E. O.
PETAL protocol: A phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma
2023-01-01 Fessas, P.; Scheiner, B.; D'Alessio, A.; M Fulgenzi, C. A.; Korolewicz, J.; Ward, C.; Tait, P.; Thomas, R.; Cortellini, A.; Sharma, R.; Pinato, D. J.
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer
2023-01-01 Cortellini, A; D'Alessio, A; Cleary, S; Buti, S; Bersanelli, M; Bordi, P; Tonini, G; Vincenzi, B; Tucci, M; Russo, A; Pantano, F; Russano, M; Stucci, Ls; Sergi, Mc; Falconi, M; Zarzana, Ma; Santini, D; Spagnolo, F; Tanda, Et; Rastelli, F; Giorgi, Fc; Pergolesi, F; Giusti, R; Filetti, M; Lo Bianco, F; Marchetti, P; Botticelli, A; Gelibter, A; Siringo, M; Ferrari, M; Marconcini, R; Vitale, Mg; Nicolardi, L; Chiari, R; Ghidini, M; Nigro, O; Grossi, F; De Tursi, M; Di Marino, P; Queirolo, P; Bracarda, S; Macrini, S; Inno, A; Zoratto, F; Veltri, E; Spoto, C; Vitale, Mg; Cannita, K; Gennari, A; Morganstein, Dl; Mallardo, D; Nibid, L; Sabarese, G; Brunetti, L; Perrone, G; Ascierto, Pa; Ficorella, C; Pinato, Dj
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis
2023-01-01 Anpalakhan, S.; Huddar, P.; Behrouzi, R.; Signori, A.; Cave, J.; Comins, C.; Cortellini, A.; Addeo, A.; Escriu, C.; Mckenzie, H.; Barone, G.; Murray, L.; Pinato, D. J.; Ottensmeier, C.; Campos, S.; Muthuramalingam, S.; Chan, S.; Gomes, F.; Banna, G. L.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
2023-01-01 Talbot, T.; D'Alessio, A.; Pinter, M.; Balcar, L.; Scheiner, B.; Marron, T. U.; Jun, T.; Dharmapuri, S.; Ang, C.; Saeed, A.; Hildebrand, H.; Muzaffar, M.; Fulgenzi, C. A. M.; Amara, S.; Naqash, A. R.; Gampa, A.; Pillai, A.; Wang, Y.; Khan, U.; Lee, P. -C.; Huang, Y. -H.; Bengsch, B.; Bettinger, D.; Mohamed, Y. I.; Kaseb, A.; Pressiani, T.; Personeni, N.; Rimassa, L.; Nishida, N.; Kudo, M.; Weinmann, A.; Galle, P. R.; Muhammed, A.; Cortellini, A.; Vogel, A.; Pinato, D. J.
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma
2023-01-01 Pinato, D. J.; Li, X.; Mishra-Kalyani, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Scheiner, B.; Pinter, M.; Wei, G.; Schneider, J.; Rivera, D. R.; Pazdur, R.; Theoret, M. R.; Casak, S.; Lemery, S.; Fashoyin-Aje, L.; Cortellini, A.; Pelosof, L.
Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis
2023-01-01 Openshaw, M. R.; Gervasi, E.; Fulgenzi, C. A. M.; Pinato, D. J.; Dalla Pria, A.; Bower, M.
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images with Outcomes of Immunotherapy in Patients with NSCLC
2023-01-01 Rakaee, M.; Adib, E.; Ricciuti, B.; Sholl, L. M.; Shi, W.; Alessi, J. V.; Cortellini, A.; Fulgenzi, C. A. M.; Viola, P.; Pinato, D. J.; Hashemi, S.; Bahce, I.; Houda, I.; Ulas, E. B.; Radonic, T.; Vayrynen, J. P.; Richardsen, E.; Jamaly, S.; Andersen, S.; Donnem, T.; Awad, M. M.; Kwiatkowski, D. J.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study
2023-01-01 Anpalakhan, S.; Huddar, P.; Behrouzi, R.; Signori, A.; Cave, J.; Comins, C.; Cortellini, A.; Addeo, A.; Escriu, C.; Mckenzie, H.; Barone, G.; Murray, L.; Bhatnagar, G.; Pinato, D. J.; Ottensmeier, C.; Gomes, F.; Banna, G. L.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
2023-01-01 Makrakis, D.; Bakaloudi, D. R.; Talukder, R.; Lin, G. I.; Diamantopoulos, L. N.; Jindal, T.; Vather-Wu, N.; Zakharia, Y.; Tripathi, N.; Agarwal, N.; Dawsey, S.; Gupta, S.; Lu, E.; Drakaki, A.; Liu, S.; Zakopoulou, R.; Bamias, A.; Fulgenzi, C. -M.; Cortellini, A.; Pinato, D.; Barata, P.; Grivas, P.; Khaki, A. R.; Koshkin, V. S.
Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma
2022-01-01 Johnson, Philip James; Pinato, David J; Kalyuzhnyy, Anton; Toyoda, Hidenori
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference
2022-01-01 Colmenero, Jordi; Tabrizian, Parissa; Bhangui, Prashant; Pinato, David James; Rodríguez-Perálvarez, Manuel L; Sapisochin, Gonzalo; Bhoori, Sherrie; Pascual, Sonia; Senzolo, Marco; Al-Adra, David; Herrero, J Ignacio; Petrowsky, Henrik; Dawson, Laura A; Hosni, Ali; Kutzke, Jade L; Gastaca, Mikel; Watt, Kymberly D
COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinoma
2022-01-01 Cabibbo, Giuseppe; Celsa, Ciro; D'Alessio, Antonio; Fulgenzi, Claudia A M; Pinato, David J
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis
2022-01-01 Mishra, G.; Majeed, A.; Dev, A.; Eslick, G. D.; Pinato, D. J.; Izumoto, H.; Hiraoka, A.; Huo, T. -I.; Liu, P. -H.; Johnson, P. J.; Roberts, S. K.
Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre
2022-01-01 Monroy-Iglesias, M. J.; Tremble, K.; Russell, B.; Moss, C.; Dolly, S.; Sita-Lumsden, A.; Cortellini, A.; Pinato, D. J.; Rigg, A.; Karagiannis, S. N.; Van Hemelrijck, M.
Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort
2022-01-01 Mallardo, D.; Cortellini, A.; Capone, M.; Madonna, G.; Pinato, D. J.; Warren, S.; Simeone, E.; Ascierto, P. A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma | 1-gen-2023 | Scheiner, B.; Roessler, D.; Phen, S.; Lim, M.; Pomej, K.; Pressiani, T.; Cammarota, A.; Frundt, T. W.; von Felden, J.; Schulze, K.; Himmelsbach, V.; Finkelmeier, F.; Deibel, A.; Siebenhuner, A. R.; Shmanko, K.; Radu, P.; Schwacha-Eipper, B.; Ebert, M. P.; Teufel, A.; Djanani, A.; Hucke, F.; Balcar, L.; Philipp, A. B.; Hsiehchen, D.; Venerito, M.; Sinner, F.; Trauner, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Pinato, D. J.; Peck-Radosavljevic, M.; Dufour, J. -F.; Weinmann, A.; Kremer, A. E.; Singal, A. G.; De Toni, E. N.; Rimassa, L.; Pinter, M. | |
| Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma | 1-gen-2023 | Vithayathil, M.; D'Alessio, A.; Fulgenzi, C. A. M.; Nishida, N.; Schonlein, M.; von Felden, J.; Schulze, K.; Wege, H.; Saeed, A.; Wietharn, B.; Hildebrand, H.; Wu, L.; Ang, C.; Marron, T. U.; Weinmann, A.; Galle, P. R.; Bettinger, D.; Bengsch, B.; Vogel, A.; Balcar, L.; Scheiner, B.; Lee, P. -C.; Huang, Y. -H.; Amara, S.; Muzaffar, M.; Naqash, A. R.; Cammarota, A.; Zanuso, V.; Pressiani, T.; Pinter, M.; Cortellini, A.; Kudo, M.; Rimassa, L.; Pinato, D. J.; Sharma, R. | |
| Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials | 1-gen-2023 | Fulgenzi, C. A. M.; Scheiner, B.; Korolewicz, J.; Stikas, C. -V.; Gennari, A.; Vincenzi, B.; Openshaw, M. R.; Silletta, M.; Pinter, M.; Cortellini, A.; Scotti, L.; D'Alessio, A.; Pinato, D. J. | |
| Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer | 1-gen-2023 | Tagliamento, Marco; Gennari, Alessandra; Lambertini, Matteo; Salazar, Ramon; Harbeck, Nadia; Del Mastro, Lucia; Aguilar-Company, Juan; Bower, Mark; Sharkey, Rachel; Dalla Pria, Alessia; Plaja, Andrea; Jackson, Amanda; Handford, Jasmine; Sita-Lumsden, Ailsa; Martinez-Vila, Clara; Matas, Marta; Miguel Rodriguez, Ana; Vincenzi, Bruno; Tonini, Giuseppe; Bertuzzi, Alexia; Brunet, Joan; Pedrazzoli, Paolo; D'Avanzo, Francesca; Biello, Federica; Sinclair, Alasdair; Lee, Alvin J X; Rossi, Sabrina; Rizzo, Gianpiero; Mirallas, Oriol; Pimentel, Isabel; Iglesias, Maria; Sanchez de Torre, Ana; Guida, Annalisa; Berardi, Rossana; Zambelli, Alberto; Tondini, Carlo; Filetti, Marco; Mazzoni, Francesca; Mukherjee, Uma; Diamantis, Nikolaos; Parisi, Alessandro; Aujayeb, Avinash; Prat, Aleix; Libertini, Michela; Grisanti, Salvatore; Rossi, Maura; Zoratto, Federica; Generali, Daniele; Saura, Cristina; Lyman, Gary H; Kuderer, Nicole M; Pinato, David J; Cortellini, Alessio | |
| A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC | 1-gen-2023 | Chen, M.; Lu, H.; Copley, S. J.; Han, Y.; Logan, A.; Viola, P.; Cortellini, A.; Pinato, D. J.; Power, D.; Aboagye, E. O. | |
| PETAL protocol: A phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma | 1-gen-2023 | Fessas, P.; Scheiner, B.; D'Alessio, A.; M Fulgenzi, C. A.; Korolewicz, J.; Ward, C.; Tait, P.; Thomas, R.; Cortellini, A.; Sharma, R.; Pinato, D. J. | |
| Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer | 1-gen-2023 | Cortellini, A; D'Alessio, A; Cleary, S; Buti, S; Bersanelli, M; Bordi, P; Tonini, G; Vincenzi, B; Tucci, M; Russo, A; Pantano, F; Russano, M; Stucci, Ls; Sergi, Mc; Falconi, M; Zarzana, Ma; Santini, D; Spagnolo, F; Tanda, Et; Rastelli, F; Giorgi, Fc; Pergolesi, F; Giusti, R; Filetti, M; Lo Bianco, F; Marchetti, P; Botticelli, A; Gelibter, A; Siringo, M; Ferrari, M; Marconcini, R; Vitale, Mg; Nicolardi, L; Chiari, R; Ghidini, M; Nigro, O; Grossi, F; De Tursi, M; Di Marino, P; Queirolo, P; Bracarda, S; Macrini, S; Inno, A; Zoratto, F; Veltri, E; Spoto, C; Vitale, Mg; Cannita, K; Gennari, A; Morganstein, Dl; Mallardo, D; Nibid, L; Sabarese, G; Brunetti, L; Perrone, G; Ascierto, Pa; Ficorella, C; Pinato, Dj | |
| Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis | 1-gen-2023 | Anpalakhan, S.; Huddar, P.; Behrouzi, R.; Signori, A.; Cave, J.; Comins, C.; Cortellini, A.; Addeo, A.; Escriu, C.; Mckenzie, H.; Barone, G.; Murray, L.; Pinato, D. J.; Ottensmeier, C.; Campos, S.; Muthuramalingam, S.; Chan, S.; Gomes, F.; Banna, G. L. | |
| Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study | 1-gen-2023 | Talbot, T.; D'Alessio, A.; Pinter, M.; Balcar, L.; Scheiner, B.; Marron, T. U.; Jun, T.; Dharmapuri, S.; Ang, C.; Saeed, A.; Hildebrand, H.; Muzaffar, M.; Fulgenzi, C. A. M.; Amara, S.; Naqash, A. R.; Gampa, A.; Pillai, A.; Wang, Y.; Khan, U.; Lee, P. -C.; Huang, Y. -H.; Bengsch, B.; Bettinger, D.; Mohamed, Y. I.; Kaseb, A.; Pressiani, T.; Personeni, N.; Rimassa, L.; Nishida, N.; Kudo, M.; Weinmann, A.; Galle, P. R.; Muhammed, A.; Cortellini, A.; Vogel, A.; Pinato, D. J. | |
| Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma | 1-gen-2023 | Pinato, D. J.; Li, X.; Mishra-Kalyani, P.; D'Alessio, A.; Fulgenzi, C. A. M.; Scheiner, B.; Pinter, M.; Wei, G.; Schneider, J.; Rivera, D. R.; Pazdur, R.; Theoret, M. R.; Casak, S.; Lemery, S.; Fashoyin-Aje, L.; Cortellini, A.; Pelosof, L. | |
| Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis | 1-gen-2023 | Openshaw, M. R.; Gervasi, E.; Fulgenzi, C. A. M.; Pinato, D. J.; Dalla Pria, A.; Bower, M. | |
| Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images with Outcomes of Immunotherapy in Patients with NSCLC | 1-gen-2023 | Rakaee, M.; Adib, E.; Ricciuti, B.; Sholl, L. M.; Shi, W.; Alessi, J. V.; Cortellini, A.; Fulgenzi, C. A. M.; Viola, P.; Pinato, D. J.; Hashemi, S.; Bahce, I.; Houda, I.; Ulas, E. B.; Radonic, T.; Vayrynen, J. P.; Richardsen, E.; Jamaly, S.; Andersen, S.; Donnem, T.; Awad, M. M.; Kwiatkowski, D. J. | |
| The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study | 1-gen-2023 | Anpalakhan, S.; Huddar, P.; Behrouzi, R.; Signori, A.; Cave, J.; Comins, C.; Cortellini, A.; Addeo, A.; Escriu, C.; Mckenzie, H.; Barone, G.; Murray, L.; Bhatnagar, G.; Pinato, D. J.; Ottensmeier, C.; Gomes, F.; Banna, G. L. | |
| Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma | 1-gen-2023 | Makrakis, D.; Bakaloudi, D. R.; Talukder, R.; Lin, G. I.; Diamantopoulos, L. N.; Jindal, T.; Vather-Wu, N.; Zakharia, Y.; Tripathi, N.; Agarwal, N.; Dawsey, S.; Gupta, S.; Lu, E.; Drakaki, A.; Liu, S.; Zakopoulou, R.; Bamias, A.; Fulgenzi, C. -M.; Cortellini, A.; Pinato, D.; Barata, P.; Grivas, P.; Khaki, A. R.; Koshkin, V. S. | |
| Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma | 1-gen-2022 | Johnson, Philip James; Pinato, David J; Kalyuzhnyy, Anton; Toyoda, Hidenori | |
| De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference | 1-gen-2022 | Colmenero, Jordi; Tabrizian, Parissa; Bhangui, Prashant; Pinato, David James; Rodríguez-Perálvarez, Manuel L; Sapisochin, Gonzalo; Bhoori, Sherrie; Pascual, Sonia; Senzolo, Marco; Al-Adra, David; Herrero, J Ignacio; Petrowsky, Henrik; Dawson, Laura A; Hosni, Ali; Kutzke, Jade L; Gastaca, Mikel; Watt, Kymberly D | |
| COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinoma | 1-gen-2022 | Cabibbo, Giuseppe; Celsa, Ciro; D'Alessio, Antonio; Fulgenzi, Claudia A M; Pinato, David J | |
| Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis | 1-gen-2022 | Mishra, G.; Majeed, A.; Dev, A.; Eslick, G. D.; Pinato, D. J.; Izumoto, H.; Hiraoka, A.; Huo, T. -I.; Liu, P. -H.; Johnson, P. J.; Roberts, S. K. | |
| Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre | 1-gen-2022 | Monroy-Iglesias, M. J.; Tremble, K.; Russell, B.; Moss, C.; Dolly, S.; Sita-Lumsden, A.; Cortellini, A.; Pinato, D. J.; Rigg, A.; Karagiannis, S. N.; Van Hemelrijck, M. | |
| Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort | 1-gen-2022 | Mallardo, D.; Cortellini, A.; Capone, M.; Madonna, G.; Pinato, D. J.; Warren, S.; Simeone, E.; Ascierto, P. A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile